Difference between revisions of "Regulatory Toxicology and Pharmacology"
| Line 55: | Line 55: | ||
[[Category:Pharmaceutical Industry]] | [[Category:Pharmaceutical Industry]] | ||
[[Category:Pharmaceutical policy groups]] | [[Category:Pharmaceutical policy groups]] | ||
| − | [[Category:Chemical Industry]] | + | [[Category:Chemical Industry]][[Category:Academic Journals]] |
Revision as of 09:17, 31 January 2011
|
This article is part of the Pharma_Portal project of Spinwatch. |
Regulatory Toxicology and Pharmacology (RTP) is a scientific journal sponsored by the chemical and pharmaceutical industry lobby group, the International Society of Regulatory Toxicology and Pharmacology (ISRTP), and published by Elsevier Science.[1][2]
ISRTP says its aim is “to identify and promote improvements in the scientific basis for regulatory decisions”.[3]
Contents
Funders
ISRTP counts among its sponsors past and present:[4]
- The American Chemistry Council, a chemical industry lobby group
- Bristol-Myers Squibb Company
- Dow AgroSciences
- Indespec Chemical Corporation
- Merck and Co., Inc.
- Monsanto
- The Procter & Gamble Company
- RJ Reynolds Tobacco Company
- The Sapphire Group, Inc.
- Schering-Plough Research Institute
- SmithKline Beecham Pharmaceuticals
- The Weinberg Group, a consulting firm that, according to a Vanity Fair article, “works for chemical companies to manufacture uncertainty about the health and environmental effects of chemicals, with the aim of fighting off regulatory and legal challenges”.[5]
Congressional investigation over bisphenol A
In 2008, US Congressman John D. Dingell, chairman of the House Energy and Commerce Committee, launched an investigation into the role of the American Chemistry Council, the Weinberg Group, ISRTP, and its journal, RTP, in the regulatory failure that led to the continuing use of the chemical bisphenol A.[6][7] Dingell said, “The tactics apparently employed by the Weinberg Group raise serious questions about whether science is for sale at these consulting groups, and the effect this faulty science might have on the public health.”[8]
Criticism
In his book, Doubt Is Their Product: How Industry's Assault on Science Threatens Your Health, former US Assistant Secretary of Energy David Michaels describes RTP as the best known of the industry-captured or “vanity journals that present themselves to the unwary as independent sources on information and science, but the peer reviewers are carefully chosen, like-minded corporate consultants sitting in friendly judgement on studies that are exquisitely structured to influence a regulatory proceeding or court case.”[9]
People
Affiliations
Contact
- Address:
- Phone:
- Email:
- Website:
Resources
(resources go here in alphabetical order)
Notes
- ↑ Elsevier. 2011. Regulatory Toxicology and Pharmacology (web page acc 31 Jan 2011)
- ↑ ISRTP. 2008. The Journal, web page acc 31 Jan 2011
- ↑ International Society of Regulatory Toxicology and Pharmacology. 2000. About ISRTP. ISRTP web page only available in web archive (archived August 18, 2000).
- ↑ International Society of Regulatory Toxicology and Pharmacology. 2008. Sponsors. ISRTP web page only available in web archive (archived February 2, 2008).
- ↑ Roberts, D. 2008. Uncovering the Weinberg Group. Vanity Fair. April 28.
- ↑ Roberts, D. 2008. Uncovering the Weinberg Group. Vanity Fair. April 28.
- ↑ Dingell, Rep. J. D. (D-Mich.). Letter to Jack N. Gerard, president and CEO, American Chemistry Council, April 2, 2008. The text of the letter can be seen here
- ↑ Layton, L. 2008. Studies on chemical in plastics questioned. Washington Post. April 27, 2008.
- ↑ Michaels, D. Doubt Is Their Product: How Industry's Assault on Science Threatens Your Health. Oxford University Press, 2008.
